Dr. Rogerio I. Neves, MD

Dr. Neves practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Neves' NPI, 1548391980, was assigned on March 8, 2007. Dr. Neves graduated from Other in 1985. Dr. Neves holds Florida license MFC1851.

Dr. Neves' primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Neves also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Dr. Neves' primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Neves to 1 more breast imaging center, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Neves practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Neves' primary specialty in the NPI Registry, under taxonomy code 208200000X. Dmand AI has Dr. Neves' licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists cancerous skin growth removal among the conditions Dr. Neves treats.

CMS data shows 104 Medicare services from Dr. Neves across 7 procedure codes in 2024, for 80 Medicare patients. Medicare paid $26,614 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Neves in 2024. The largest group is 75 to 84, with 40 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Neves' median patient age at 74, with 32% women.

In 2024, Dr. Neves wrote 12 Medicare Part D claims. They cover 1 drug, with $281,526 in total drug cost. In 2020, CMS named 74 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Neves for performance year 2024, reported as part of a group. Dr. Neves accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 131 procedures of melanoma (skin cancer) excision by Dr. Neves, more than 95% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 71 papers to Dr. Neves, published from 2008 to 2024. 2016 was the busiest year, with 4. The most frequent topics are Melanoma, Skin Neoplasms and Surgical Flaps. Dr. Neves has published most often in Ann Plast Surg. Dr. Neves' most frequent co-authors are Joseph J. Drabick, MD, Heath Brandon Mackley, MD and Colette R. Pameijer, MD.

Dmand AI links Dr. Neves to 12 clinical trials, 4 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Melanoma, Nevi and Melanomas and Brain Neoplasms. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 41 general payments to Dr. Neves from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Sanofi and Genzyme US Companies paid the most, $16,721. It also lists 38 research payments totaling $3,079 from 2020 to 2023.

Dmand AI lists 21 awards for Dr. Neves, most recently Listed in Best Doctors in America in 2015.

Dr. Neves graduated from Other in 1985. Dr. Neves is a member of American Association of Plastic Surgeons, ACS, ASCO, ASPS, European Association of Dermato-Oncology and Plastic Surgery Research Council.

Dr. Neves is in network with 10 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.